Kynam Capital Management’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-6,004
| Closed | -$43.4K | – | 27 |
|
|
2023
Q3 | $43.4K | Buy |
6,004
+12
| +0.2% | +$87 | 0.01% | 27 |
|
|
2023
Q2 | $31.6K | Hold |
5,992
| – | – | ﹤0.01% | 23 |
|
|
2023
Q1 | $18.6K | Sell |
5,992
-6,073
| -50% | -$18.9K | ﹤0.01% | 34 |
|
|
2022
Q4 | $47.7K | Buy |
12,065
+40
| +0.3% | +$158 | 0.01% | 31 |
|
|
2022
Q3 | $45K | Sell |
12,025
-433
| -3% | -$1.62K | 0.01% | 33 |
|
|
2022
Q2 | $166K | Sell |
12,458
-1,687
| -12% | -$22.5K | 0.04% | 30 |
|
|
2022
Q1 | $70K | Sell |
14,145
-654
| -4% | -$3.24K | 0.02% | 31 |
|
|
2021
Q4 | $101K | Buy |
+14,799
| New | +$101K | 0.05% | 30 |
|